If you or a loved one has struggled with psoriasis, you know how frustrating it can be to find a treatment that’s effective, safe, and kind to your skin. For decades, phototherapy has been a cornerstone of psoriasis management, but recent advancements have elevated one particular option to the forefront: the 308-nm excimer laser. This targeted, powerful treatment is revolutionizing how we address psoriasis—and even showing promise for other skin conditions. Let’s dive into what makes it so special, backed by decades of clinical research.

What Is the 308-nm Excimer Laser, Anyway?

First, let’s break down the basics. The 308-nm excimer laser is a type of ultraviolet (UV) phototherapy that delivers a precise wavelength of light—308 nanometers—directly to affected skin areas (Morita, 2018). Unlike broad-spectrum UV therapies that expose large swaths of healthy skin to radiation, this laser is hyper-targeted: it only treats the patches of psoriasis, sparing surrounding tissue from unnecessary exposure (Feldman et al., 2002). This targeted approach is a game-changer, especially for patients with localized or mild-to-moderate plaque psoriasis—the most common form of the condition.

It joins other established phototherapy methods like narrowband UV-B (NB-UVB) and bath-psoralen UV-A (bath-PUVA) in leveraging UV light’s immunoregulatory effects, but its unique wavelength and delivery system set it apart (Morita, 2018). Over the years, technological upgrades—such as the Multi Micro Dose (MMD®) tip—have made it even more effective, allowing clinicians to deliver an optimal therapeutic dose (OTD™) tailored to each patient (Marchetti et al., 2020).

Why It Works: The Science Behind the Laser

The 308-nm excimer laser’s success boils down to two key mechanisms: apoptosis (cell death) and immune suppression—the same dual actions that make UV phototherapy effective for psoriasis, but with enhanced precision (Morita, 2018). Here’s a deeper look at the research-backed science:

• T-Cell Depletion: Psoriasis is driven by overactive pathogenic T cells that trigger inflammation and abnormal skin cell growth. The 308-nm laser penetrates the skin more effectively than conventional UVB, directly targeting and eliminating these harmful T cells in both the epidermis (outer skin layer) and dermis (inner skin layer) (Bianchi et al., 2003). At the same time, it boosts levels of regulatory T cells—immune cells that calm inflammation and restore balance to the skin’s immune system (Morita, 2018).
• Apoptosis of Abnormal Cells: The laser induces programmed cell death (apoptosis) in overproliferating keratinocytes (the main skin cells affected by psoriasis) (Bianchi et al., 2003). Research shows this process is fueled by molecular changes: irradiation upregulates the p53 gene (a key regulator of cell death) and downregulates Bcl-2 (a protein that inhibits apoptosis), creating a cascade that clears thick, scaly plaques (Bianchi et al., 2003).

In short, the laser doesn’t just treat symptoms—it targets the root immunological causes of psoriasis.

Clinical Results: What the Research Shows

Decades of clinical studies confirm that the 308-nm excimer laser is one of the most effective psoriasis treatments available. Let’s look at the data:

• A multicenter trial of 124 patients with mild-to-moderate plaque psoriasis found that 72% of those who completed the protocol achieved at least 75% clearing of their target plaque after an average of just 6.2 treatments (Feldman et al., 2002). Even more impressively, 84% of patients reached 75% or better improvement after 10 or fewer sessions, and 50% saw 90% or more clearing (Feldman et al., 2002).
• A retrospective review of 98 patients with localized stable psoriasis reported similar success: 60.2% achieved significant improvement (≥70% clearing) with an average of 17 sessions, while 24.5% saw good improvement (50%-70% clearing) after 12 sessions (Hadi et al., 2010). Side effects were minimal—limited to sunburn-like reactions that were well-tolerated (Hadi et al., 2010).

Beyond efficacy, the laser offers practical benefits. Unlike traditional phototherapy, which often requires weekly visits for months, the 308-nm laser delivers results in far fewer sessions (Feldman et al., 2002). This not only saves patients time but also improves adherence—a key factor in treatment success (Marchetti et al., 2020).

Safety and Cost-Effectiveness: Why It Stands Out

Safety is a top concern for any psoriasis treatment, and the 308-nm excimer laser delivers here too. Common side effects are mild and temporary: erythema (redness), blisters, hyperpigmentation (darkening of the skin), and occasional erosions (Feldman et al., 2002; Hadi et al., 2010). Unlike systemic medications that can affect internal organs, the laser’s targeted delivery minimizes systemic risks—making it a great option for patients who can’t tolerate oral or injectable treatments.

From a cost perspective, the laser is also gaining traction. When paired with the MMD® accessory, it delivers incremental clinical benefits while offering significant cost savings for payers and patients alike (Marchetti et al., 2020). This is especially relevant in the context of the COVID-19 pandemic, where cost-effective, low-risk treatments are more important than ever (Marchetti et al., 2020).

Beyond Psoriasis: Emerging Uses

While psoriasis is the laser’s primary focus, research suggests it has potential for other skin conditions. A 2023 study highlighted its efficacy in treating mycosis fungoides—a type of cutaneous lymphoma—expanding its role beyond inflammatory skin diseases (Sosh et al., 2023). As research continues, we may see even more applications for this versatile tool.

Is the 308-nm Excimer Laser Right for You?

If you have localized, stable psoriasis (or even mild-to-moderate widespread disease), the 308-nm excimer laser is worth discussing with your dermatologist. It’s particularly ideal if:

• You want a targeted treatment that spares healthy skin.
• You’re frustrated with slow-acting or ineffective therapies.
• You prefer minimal side effects and no systemic risks.
• You need a treatment that fits into a busy schedule (fewer sessions = less time spent on appointments).

As with any treatment, results vary by individual—factors like disease severity, skin type, and adherence play a role (Marchetti et al., 2020). But for many patients, this laser is a lifeline: a way to regain control of their skin without sacrificing safety or quality of life.

The Bottom Line

The 308-nm excimer laser isn’t just another psoriasis treatment—it’s a testament to how targeted medical technology can transform patient care. Backed by decades of research (Morita, 2018; Feldman et al., 2002; Hadi et al., 2010), it offers unmatched efficacy, safety, and convenience, making it a top choice for dermatologists and patients worldwide. Whether you’re new to psoriasis treatment or looking to switch from a less effective option, the 308-nm excimer laser is a game-changer worth exploring.

Always consult with a board-certified dermatologist to determine if this treatment is right for your unique needs. With the right care, clear skin is within reach—and the 308-nm excimer laser is helping more people achieve it than ever before.

References

• Bianchi, B., Campolmi, P., Mavilia, L., Danesi, A., Rossi, R., & Cappugi, P. (2003). Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis. Journal of the European Academy of Dermatology and Venereology, 17(4), 408-413.https://pubmed.ncbi.nlm.nih.gov/12834450/
• Feldman, S. R., Mellen, B. G., Housman, T. S., Fitzpatrick, R. E., Geronemus, R. G., Friedman, P. M., Vasily, D. B., & Morison, W. L. (2002). Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. Journal of the American Academy of Dermatology, 46(6), 900-906.https://pubmed.ncbi.nlm.nih.gov/12063488/
• Hadi, S. M., Al-Quran, H., de Sá Earp, A. P., Hadi, A. S., & Lebwohl, M. (2010). The use of the 308-nm excimer laser for the treatment of psoriasis. Photomedicine and Laser Surgery, 28(5), 693-695.https://pubmed.ncbi.nlm.nih.gov/20932176/
• Marchetti, A., Bhutani, T., Lockshin, B., Siegel, D. M., & Behringer, F. (2020). Therapies for Psoriasis: Clinical and Economic Comparisons. Journal of Drugs in Dermatology, 19(11), 1101-1108.https://pubmed.ncbi.nlm.nih.gov/33196750/
• Morita, A. (2018). Current developments in phototherapy for psoriasis. Journal of Dermatology, 45(3), 287-292.https://pubmed.ncbi.nlm.nih.gov/29369396/
• Sosh, D., Hyde, J., & Dulmage, B. (2023). The efficacy of 308-nm excimer laser in the treatment of mycosis fungoides. International Journal of Dermatology, 62(2), e92-e93.https://pubmed.ncbi.nlm.nih.gov/35049052/